\
&
Contact us
\
&
Contact us
Partnership website: https://bluepartnership.eu/
The proposed partnership will enable a just and inclusive transition to a climate-neutral, sustainable and productive blue economy through key intervention areas providing for a healthy ocean, the wellbeing of citizens, and a blue economy that is in harmony with nature and whose benefits are distributed fairly.
The SBEP targets the Green Deal and Digital Europe objectives and contributes to the Global Earth Observing System, by mobilising relevant quadruple helix stakeholders who will co-create and co-deliver knowledge-based solutions and innovative governance models, and by combining financial resources for joint transnational calls and resources for other activities.
The integration of sea-basins initiatives and strategies will ensure that impact is delivered at local, regional, national and international levels.
Draft partnership proposal (July 2020)
Contact
Commission services: Wendy Bonne, Eduardo Carqueijeiro
Partners: Ministry of University and Research (Italy) and Co-coordinator Research Council of Norway and 58 other partners https://bluepartnership.eu
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
fernanda.werneck@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
